Tests could spare chemotherapy

Thousands of breast cancer patients may not need chemotherapy after a new test to determine whether it is necessary was approved by the National Institute of Health and Care Excellence. Research was carried out by a Hywel Dda health board surgeon.

View all 5 updates ›

Test will have 'major impact' on breast cancer patients

The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.

During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.

This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."

– Simon Holt, Consultant Surgical Oncologist Hywel Dda Health Board

The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.

More top news